Skip to contentD
DNA X, Inc.
D
SONMDNA X, Inc. Q2 2021 · 10-Q
Revenue$11.95M$11.95M−43.2% vs Q2 2020 Net Income-$6.69M-$6.69MN/M vs Q2 2020 EPS Diluted-$0.10-$0.10N/M vs Q2 2020 Gross Profit$2,654,000−46.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
DNA X, Inc. · CIK 1178697 · Engraved from SEC EDGAR
Operating Cash Flowderived-$7,017,000N/M Margins · derivedGross margin22.2%−1.2 pt vs Q2 2020
Operating margin-54.3%−22.8 pt vs Q2 2020
Net margin-55.9%−22.2 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end